Latest Advances

  • Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
  • Journal: The American journal of case reports
  • Treatment Used: Hemodialysis, Corticosteroids, Plasma Exchange, and Eculizumab
  • Number of Patients: 1
  • Published —
This case report describes a 58-year-old man diagnosed with atypical hemolytic uremic syndrome (aHUS) treated with hemodialysis, corticosteroids, plasma exchange, and eculizumab.
  • Condition: Urate Nephropathy from Tumor Lysis Syndrome (TLS) in an Undiagnosed Case of Prostate Cancer
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Urgent Hemodialysis
  • Number of Patients: 1
  • Published —
This case report describes a patient with metastatic prostate cancer which remained undiagnosed until the patient developed tumor lysis syndrome (TLS), leading to urate nephropathy treated with urgent hemodialysis.
  • Condition: Atypical Hemolytic Uremic Syndrome
  • Journal: BMC nephrology
  • Treatment Used: Ravulizumab
  • Number of Patients: 8
  • Published —
The study researched the outcomes of ravulizumab for atypical hemolytic uremic syndrome triggered by pregnancy.
  • Condition: Adult Patients with Atypical Hemolytic-Uremic Syndrome (aHUS)
  • Journal: Terapevticheskii arkhiv
  • Treatment Used: Russian Biosimilar of the Drug Eculizumab
  • Number of Patients: 3
  • Published —
This study evaluated the effectiveness and safety of the Russian biosimilar (highly similar to another already approved biological medicine) of the drug eculizumab for adult patients with atypical hemolytic-uremic syndrome (disease that causes abnormal blood clots to form in small blood vessels in the kidneys; aHUS).
  • Condition: Carfilzomib-Induced Hemolytic and Uremic Syndrome
  • Journal: Nephrologie & therapeutique
  • Treatment Used: Eculizumab
  • Number of Patients: NULL
  • Published —
The study researched the outcomes of eculizumab for treating carfilzomib-induced haemolytic and uremic syndrome.
  • Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
  • Journal: Kidney international
  • Treatment Used: Ravulizumab vs Eculizumab
  • Number of Patients: 0
  • Published —
This study evaluated ravulizumab versus eculizumab in patients with atypical hemolytic uremic syndrome (disease that causes abnormal blood clots to form in small blood vessels in the kidneys; aHUS).
  • Condition: Kidney Transplant Recipients with Atypical Hemolytic Uremic Syndrome
  • Journal: BMC nephrology
  • Treatment Used: Eculizumab
  • Number of Patients: 36
  • Published —
The study researched the use of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome.
  • Condition: Diacylglycerol Kinase Epsilon Nephropathy
  • Journal: Kidney international
  • Treatment Used: Eculizumab
  • Number of Patients: 16
  • Published —
In this study, researchers evaluated the effectiveness of using eculizumab for the treatment of diacylglycerol kinase epsilon nephropathy.
  • Condition: Atypical Hemolytic Uremic Syndrome Naive To Completment Inhibitor Treatment
  • Journal: Kidney international
  • Treatment Used: Ravulizumab
  • Number of Patients: 58
  • Published —
The purpose of the study was to evaluate the effectiveness and safety of ravulizumab in adults with atypical hemolytic uremic syndrome presenting with thrombotic microangiopathy.
  • Condition: Prevention of Meningococcal Infection in Infants with Atypical Hemolytic Uremic Syndrome Taking Eculizumab
  • Journal: CEN case reports
  • Treatment Used: Prophylactic amoxicillin
  • Number of Patients: 0
  • Published —
This case series describes prophylactic amoxicillin for the prevention of meningococcal infection in infants with atypical hemolytic uremic syndrome taking eculizumab.
  • Condition: Serogroup Meningococci Infection with Atypical Hemolytic Uremic Syndrome
  • Journal: Bioscience reports
  • Treatment Used: Eculizumab and Bexsero Vaccine
  • Number of Patients: 7
  • Published —
This study investigated the efficacy of using the Bexsero meningococci vaccine in patients using eculizumab to treat their atypical hemolytic uremic syndrome.
  • Condition: Acute kidney injury with severe hemolysis and thrombocytopenia due to hematotoxic (Russell's viper) snake bite
  • Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • Treatment Used: Plasmapheresis
  • Number of Patients: 1
  • Published —
The study researched the outcomes of plasmapheresis in patients with acute kidney injury with severe hemolysis and thrombocytopenia due to hematotoxic (Russell's viper) snake bite.
Showing 1-12 of 22